| Cash Flow | 2025-09-30 |
|---|---|
| Net loss | -3,747,212 |
| Unrealized gain on securities | -33,747 |
| Gain on settlement of accounts payable | 127,579 |
| Shares issued for services | 142,633 |
| Gain on change in derivative liability | 128,101 |
| Loss on derivative | 3,425,796 |
| Accounts payable and accrued expenses | 307,229 |
| Net cash used in operating activities | -93,487 |
| Proceeds from short term advances related parties | 84,800 |
| Net cash provided by financing | 84,800 |
| Net change in cash | -8,687 |
| Cash and cash equivalents at beginning of period | 13,199 |
| Cash and cash equivalents at end of period | 4,512 |
Balance Labs, Inc. (BLNC)
Balance Labs, Inc. (BLNC)